Non-aspirin NSAID use was associated with lower risk of
inflammation-related, alcohol-related, infection-related, obesity-related, smokingrelated,
head and neck, esophageal, stomach, pancreas, colorectal, lung, urinary
bladder, endometrial and prostate cancers, and myeloid monocytic leukemia.